{"name":"Karus Therapeutics Limited","slug":"karus-therapeutics-limited","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE80NGNTbTZtSFRQdi1YVkNhQVhWVk9DWUZPMzhSZzcxbG8weWRHRlVYZTJJeU1fNG9NRXcxenRVM243V2l0VnlzNGpLQVQ4TlJZVXpQWktKXzlZWGc1RTNj?oc=5","date":"2026-01-16","type":"pipeline","source":"Nature","summary":"People - Nature","headline":"People","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxNREdEeFhBaGxRZlBRQ0FWYVVwby04ZmhwTk4yU3hYOWh3VEgtRkpobzhrS2tKREgwRzFtVnRBVmk0OUNxN05MWEJTdjBhMFlIYTk2R3NnS3lIVUVtdkJyUWJBMFVKYm1WeVFXaGRlU2hrN0xNQ2lWbGU5c0pTV2ZVNUNvZjZEWkV0ZXZvTTVlU2FyazhIT01PTTNGNEJuOHRZQ0h4Z1plR191QklSUldqNHFDWlIzcGJIRkdrWXc5QVk2cnpuRnlHb2JKakhoa1VYXzBR?oc=5","date":"2025-11-17","type":"pipeline","source":"businesswire.com","summary":"Mosaic Therapeutics appoints Dr Stephen Shuttleworth as Chief Scientific Officer - businesswire.com","headline":"Mosaic Therapeutics appoints Dr Stephen Shuttleworth as Chief Scientific Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxQU3NOR1BacW9aQ1BJZHk1RjliZ3pYVW0wV3JCUkVrZE9mQkJzX2JXdU5hQ3BMQ2o4ejJST28tLUZmZl9DWTJjeTQ1b2NiNXdVVVZGMG4yVk5sU1NQc1lZOGw1cGVZSFM1SHdmdm4tNTgyaVlkdURsYWI5VW1sVWxVX282VkgwQktCM3VTbXQ1enFvVlJlZ193amdob2ZTdU5GV1NjalNHTmYxQQ?oc=5","date":"2025-11-16","type":"pipeline","source":"Business Weekly","summary":"Palo Alto scientist returns to Cambridge as Mosaic Therapeutics CSO - Business Weekly","headline":"Palo Alto scientist returns to Cambridge as Mosaic Therapeutics CSO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgJBVV95cUxQckg3T1duZlh2bXZNNnAzYXlMdkNkcUV2YXA4c2RvUFNhTW5iY3lZSmx5WXUwXzBlTTJ1eWZINW1yeFk4WlZId0haMkpUWXF0M204SzkzeE10UW9acDdWY3Q1dmQ3T0xjc0RkeUV2RzdqWEJwdVFVeTFGRFF0VS1oczVnYU1iODZIU21ORURpZlB5Q2hSSTJKLU5vcTMyOVpXQ1QwWGNWR1RTbTJXNm5xMGMwbUR3YV9hQi1LOWJJMUN1Y0xiZURpelg4SWZ0RXlfdkhrR0VnZFp1MzFFVFFNU3J5eTZVTjJnQ2ctSkRmOU5WQlprR3p4WHltSi1VUjA2UlZxZUJwOTVPMnNodGlmQndFZ0g2endieEJyYlgyMnJ3Q2k4czRVaHBpbVhUdw?oc=5","date":"2025-04-24","type":"deal","source":"businesswire.com","summary":"Mosaic Therapeutics In-Licenses Two Clinical-Stage Oncology Programs From Astex Pharmaceuticals for Development as Proprietary Combination Therapies - businesswire.com","headline":"Mosaic Therapeutics In-Licenses Two Clinical-Stage Oncology Programs From Astex Pharmaceuticals for Development as Propr","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTE9KQlpXLU5ORHZfS3VUS0dXN0FRcnZ0aXJNVUQyOE52dHdCdVhkQXkyRDhNZ0xCNWtQTnBraHFtS09aX3Q3d0JoX0Q3UldmdmdKUGF1R0c1Q0M1eXpmSmc?oc=5","date":"2024-09-04","type":"pipeline","source":"PharmaTimes","summary":"Simon Jones - PharmaTimes","headline":"Simon Jones","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxQUjJRMl9QcjVVakdRRGtLbTZBSWtYN0luNkNDbXJPSldvRHpWWE9WbG14c0xPczVsRmtTNjBCNUlROWlsSURHcXBGbW54R21OalhYTFpxcFUxemhkMHZFd2RSV2pOeFFZUjJTOW8wT3E5QlBWbDlBNDdhQlFuVDNmLTlLaGoyMVpIZ3RsbV9pcUlxVC1VQWREOVViZGluYVk?oc=5","date":"2023-03-27","type":"regulatory","source":"BioWorld News","summary":"Pharming sets $548K annual price for newly approved Joenja - BioWorld News","headline":"Pharming sets $548K annual price for newly approved Joenja","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTE5MZmh3RzF6bkVNZFd3aGR4SGhTOUVKOVBZZHJScVFVN1ZKTEU2NG11emtUWkpyWHBGYmdhUHVpbU5VRTZLdXpsVXJOaTlyLV9MYTV6a0FISjZ0MlhURHd6cS1HTjhLUy0yaE04ZFpXZkFZNjFxemc?oc=5","date":"2023-03-06","type":"pipeline","source":"pharmaphorum","summary":"Moderna picks Oxfordshire for UK facility - pharmaphorum","headline":"Moderna picks Oxfordshire for UK facility","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiW0FVX3lxTE5kRFdPcHNCaXNTekRZWmd0S0ZaOTQtSkRrZ2JLdG1wVEdvYnIzNEdqS3gwOGIxUUg4SFZQcWJHSGhzTFZTUXBWMGFCSVF1eGVwUUJoYVJ3bjZNMHM?oc=5","date":"2021-09-13","type":"pipeline","source":"Sifted","summary":"Remember the Future Fund? Here’s where the UK government’s money went - Sifted","headline":"Remember the Future Fund? Here’s where the UK government’s money went","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTE5aeFI4b2R4NE9wSDAzMklDSmVMZjlfWHVoQTRSd2dUNXZSbUFHejdZQjlmc3BEVkhoRHEwM3hfZ1RFUjJ3V0IwcjRvdkV6cUt6R09nbVh2SGFBbS1iNlhzYjRZb0ppQmpwejcwZHNYMnlOaXU0RjRF?oc=5","date":"2020-10-12","type":"regulatory","source":"calcalistech.com","summary":"Due to high demand for biotech, Pontifax crosses $1.3 billion funding threshold - calcalistech.com","headline":"Due to high demand for biotech, Pontifax crosses $1.3 billion funding threshold","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}